- Head Grower Strawberries, Australia
- Growing Manager for Hydroponic strawberry producer
- Farm Manager Costa Rica
- Regional Sales Manager Fresh Produce
- Head Grower Strawberries, Norway
- Export Trade Manager
- Business Developer - Northern Europe
- Orchard Sector Manager
- International Citrus Account Manager
First atomic-level image of the human ‘marijuana receptor’
The new insights into the human cannabinoid receptor 1 (CB1) will provide an essential tool for understanding why some molecules related to THC have unexpectedly complex and sometimes harmful effects. The findings also have the potential to guide drug design for pain, inflammation, obesity, fibrosis and other indications.
The new study, published by the journal Cell, was led by a quartet of scientists: TSRI’s Laura Bohn, Northeastern University’s Alexandros Makriyannis, Shanghai Tech University’s Zhi-Jie Liu and Shanghai Tech and University of Southern California’s Raymond C. Stevens.
At the beginning of the study, the team struggled to produce a crystal form—needed to obtain data to recreate the high-resolution structure—of the receptor bound with AM6538, a stabilizing a molecule that blocks the receptor’s action.
“The CB1 receptor proved as challenging for crystallization as it did for understanding its functional regulation and signaling,” said Bohn, who is a professor in TSRI’s Department of Molecular Therapeutics.
When the scientists succeeded in crystalizing the receptor and collecting the data, the structure of the cannabinoid receptor complex revealed an expansive and complicated binding pocket network consisting of multiple sub-pockets and channels to various regions of the receptor.
Cannabinoid receptors are part of a large class of receptors known as G protein-coupled receptors (GPCR), which account for about 40 percent of all prescription pharmaceuticals on the market and play key roles in many physiological functions. When an outside substance binds to a GPCR, it activates a G protein inside the cell to release components and create a specific cellular response.
AM6538, is an antagonist/inverse agonist that binds tightly to the receptor; it has a long half-life, making it potentially useful as a treatment of addiction disorders.
“As marijuana continues to become more common in society, it is critical that we understand how it works in the human body,” said Liu, who is professor and deputy director of the iHuman Institute of Shanghai Tech and is also affiliated with the Chinese Academy of Sciences.
The first author of the Cell study, “Crystal Structure of the Human Cannabinoid Receptor CB1,” is Tian Hua of Shanghai Tech University and the Chinese Academy of Sciences (Beijing).
In addition to Stevens, Liu, Bohn, Makriyannis and Hua, other authors of the study are Mengchen Pu, Lu Qu, Yiran Wu, Suwen Zhao, Wenqing Shui, Shanshan Li of iHuman Institute at ShanghaiTech University; Nikolai Zvonok, Anisha Korde, Kiran Vemuri of Northeastern University; Gye Won Han of University of Southern California; Robert Laprairie, Edward Stahl, and Jo-Hao Ho (graduate student) of TSRI; Irina Kufareva of University of California, San Diego; and Michael Hanson of the GPCR Consortium.
The study was supported by the Ministry of Science and Technology of China (grants 2014CB910400 and 2015CB910104), National Nature Science Foundation of China (grant 31330019), National Institutes of Health (grants P01DA009158, R37DA023142 and R01AI118985), the National Science Foundation, Shanghai Municipal Government, ShanghaiTech University and the GPCR Consortium.
For more information:
Receive the daily newsletter in your email for free | Click here
Other news in this sector:
- 2023-08-28 China works to minimize flood impact, ensure vegetable supply
- 2022-08-24 Heart Research Institute looks at ways vegetables could treat strokes
- 2021-12-13 CAN: Companies seek approval for C-19 vaccine, using plants to express proteins needed
- 2020-04-10 Spain approves hiring 80,000 unemployed and immigrants to cover farm shortfall
- 2020-03-31 US (PA): Harrisburg University still running aquaponics lab, donating produce during virus outbreak
- 2019-04-01 HortiDaily starts MMJDaily.com
- 2019-03-25 Aphria shows automation in new video
- 2019-03-06 CEA Advisors forms new division focused on cannabis industry
- 2019-03-05 Denmark: Spectrum Cannabis ready for sale in autumn
- 2019-03-05 CA (BC): Cannabis grower gets permit for growing facility
- 2019-03-01 "I think the Netherlands can become the Champagne region of cannabis"
- 2019-02-27 Belgium takes first step towards legalization of medicinal cannabis cultivation
- 2019-02-25 Canada: 'World's largest indoor organic hemp CBD grower' setting up in Manitoba
- 2019-02-14 Sustainability and the cultivation of quality cannabis
- 2019-02-11 Canopy Growth to inject 30 million CDN in additional capital into Canopy Rivers
- 2019-02-08 US (CA): Cannabis Research Center to explore environmental, social impacts of legalization
- 2019-02-08 Humidity in cannabis cultivation
- 2019-02-01 MMJ exports get approval from Israel cabinet
- 2019-01-31 US: Cannabis company files bankruptcy
- 2019-01-28 "Victoria is the medicinal cannabis capital of Australia"